A detailed history of Zhang Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Zhang Financial LLC holds 11,412 shares of ABBV stock, worth $1.9 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
11,412
Previous 9,276 23.03%
Holding current value
$1.9 Million
Previous $1.44 Million 44.61%
% of portfolio
0.15%
Previous 0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $341,375 - $388,965
2,136 Added 23.03%
11,412 $2.08 Million
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $633,372 - $713,326
4,603 Added 98.5%
9,276 $1.44 Million
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $188,495 - $218,211
-1,411 Reduced 23.19%
4,673 $696,000
Q2 2023

Jul 18, 2023

SELL
$132.51 - $164.9 $99,780 - $124,169
-753 Reduced 11.01%
6,084 $819,000
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $30,946 - $35,639
-214 Reduced 3.04%
6,837 $1.09 Million
Q4 2022

May 17, 2023

BUY
$138.31 - $165.87 $29,598 - $35,496
214 Added 3.13%
7,051 $1.14 Million
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $168,599 - $202,195
-1,219 Reduced 14.74%
7,051 $1.14 Million
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $48,718 - $55,876
363 Added 4.59%
8,270 $1.11 Million
Q2 2022

Jul 14, 2022

SELL
$137.62 - $174.96 $45,001 - $57,211
-327 Reduced 3.97%
7,907 $1.21 Million
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $397,259 - $492,887
3,010 Added 57.62%
8,234 $1.34 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $241,180 - $305,162
2,245 Added 75.36%
5,224 $707,000
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $316,965 - $359,803
2,979 New
2,979 $321,000
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $194,997 - $249,252
-2,968 Closed
0 $0
Q4 2018

May 16, 2019

BUY
$77.85 - $96.01 $231,058 - $284,957
2,968 New
2,968 $274,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Zhang Financial LLC Portfolio

Follow Zhang Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zhang Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zhang Financial LLC with notifications on news.